|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
232,140,000 |
Market
Cap: |
1.57(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$3.23 - $9.74 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Ardelyx is a biopharmaceutical company focused on discovering, developing and commercializing medicines. This includes adult patients with irritable bowel syndrome with constipation (IBS-C), adult patients with chronic kidney disease (CKD) on dialysis suffering from elevated serum phosphorus, or hyperphosphatemia; and adult patients with CKD and/or heart failure with elevated serum potassium, or hyperkalemia. Co.'s product pipeline includes among other, IBSRELA, a sodium hydrogen exchanger 3 inhibitor for the treatment of IBS-C in adults; and XPHOZAH, which is a medicine being developed for the control of serum phosphorus in adult patients with CKD on dialysis.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
585,000 |
Total Buy Value |
$0 |
$0 |
$0 |
$1,011,778 |
Total People Bought |
0 |
0 |
0 |
7 |
Total Buy Transactions |
0 |
0 |
0 |
7 |
Total Shares Sold |
780,776 |
1,206,168 |
1,357,304 |
2,009,275 |
Total Sell Value |
$6,635,429 |
$9,420,070 |
$9,994,774 |
$10,729,161 |
Total People Sold |
8 |
8 |
8 |
8 |
Total Sell Transactions |
19 |
37 |
60 |
105 |
End Date |
2024-02-25 |
2023-11-24 |
2023-05-26 |
2022-05-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Raab Michael |
President & CEO |
|
2020-03-02 |
4 |
AS |
$7.00 |
$77,861 |
D/D |
(11,123) |
208,057 |
|
-11% |
|
Raab Michael |
President & CEO |
|
2020-03-02 |
4 |
OE |
$1.08 |
$12,013 |
D/D |
11,123 |
219,180 |
|
- |
|
Raab Michael |
President & CEO |
|
2020-02-05 |
4 |
AS |
$7.32 |
$182,928 |
D/D |
(25,000) |
206,828 |
|
-8% |
|
Raab Michael |
President & CEO |
|
2020-02-05 |
4 |
OE |
$1.08 |
$27,000 |
D/D |
25,000 |
231,828 |
|
- |
|
Grammer Elizabeth A |
EVP, General Counsel |
|
2019-12-30 |
4 |
B |
$7.51 |
$496 |
I/I |
66 |
2,066 |
1.91 |
9% |
|
Baskett Forest |
10% Owner |
|
2019-12-09 |
4 |
A |
$6.25 |
$5,000,000 |
I/I |
800,000 |
3,482,186 |
|
- |
|
Mott David M |
Director |
|
2019-12-09 |
4 |
A |
$6.25 |
$2,500,000 |
I/I |
400,000 |
3,482,186 |
|
- |
|
Florence Anthony A. Jr. |
10% Owner |
|
2019-12-09 |
4 |
A |
$6.25 |
$2,500,000 |
I/I |
400,000 |
3,482,186 |
|
- |
|
Barris Peter J |
10% Owner |
|
2019-12-09 |
4 |
A |
$6.25 |
$5,000,000 |
I/I |
800,000 |
3,482,186 |
|
- |
|
Makower Joshua |
10% Owner |
|
2019-12-09 |
4 |
A |
$6.25 |
$2,500,000 |
I/I |
400,000 |
3,482,186 |
|
- |
|
Sandell Scott D |
10% Owner |
|
2019-12-09 |
4 |
A |
$6.25 |
$5,000,000 |
I/I |
800,000 |
3,482,186 |
|
- |
|
Nea 12 Gp, Llc |
10% Owner |
|
2019-12-09 |
4 |
A |
$6.25 |
$2,500,000 |
D/D |
400,000 |
9,569,210 |
|
- |
|
Kerins Patrick J |
10% Owner |
|
2019-12-09 |
4 |
A |
$6.25 |
$2,500,000 |
I/I |
400,000 |
9,569,210 |
|
- |
|
Makhzoumi Mohamad |
10% Owner |
|
2019-12-09 |
4 |
A |
$6.25 |
$2,500,000 |
I/I |
400,000 |
3,482,186 |
|
- |
|
Nea 15 Gp, Llc |
10% Owner |
|
2019-12-09 |
4 |
A |
$6.25 |
$2,500,000 |
I/I |
400,000 |
3,482,186 |
|
- |
|
Sonsini Peter W. |
10% Owner |
|
2019-12-09 |
4 |
A |
$6.25 |
$2,500,000 |
I/I |
400,000 |
3,482,186 |
|
- |
|
Grammer Elizabeth A |
EVP, General Counsel |
|
2019-12-03 |
4 |
AS |
$8.00 |
$40,000 |
D/D |
(5,000) |
118,219 |
|
- |
|
Grammer Elizabeth A |
EVP, General Counsel |
|
2019-12-03 |
4 |
OE |
$3.42 |
$17,100 |
D/D |
5,000 |
123,219 |
|
- |
|
Grammer Elizabeth A |
EVP, General Counsel |
|
2019-11-19 |
4 |
AS |
$7.00 |
$35,000 |
D/D |
(5,000) |
118,219 |
|
- |
|
Grammer Elizabeth A |
EVP, General Counsel |
|
2019-11-19 |
4 |
OE |
$3.42 |
$17,100 |
D/D |
5,000 |
123,219 |
|
- |
|
Kaufmann Mark |
Chief Financial Officer |
|
2019-10-07 |
4 |
AS |
$4.56 |
$91,190 |
D/D |
(20,000) |
141,418 |
|
- |
|
Kaufmann Mark |
Chief Financial Officer |
|
2019-10-07 |
4 |
OE |
$0.54 |
$10,800 |
D/D |
20,000 |
161,418 |
|
- |
|
Grammer Elizabeth A |
EVP, General Counsel |
|
2019-08-22 |
4 |
AS |
$3.50 |
$3,318 |
D/D |
(948) |
115,890 |
|
- |
|
Grammer Elizabeth A |
EVP, General Counsel |
|
2019-08-21 |
4 |
AS |
$3.50 |
$14,182 |
D/D |
(4,052) |
116,838 |
|
- |
|
Grammer Elizabeth A |
EVP, General Counsel |
|
2019-08-19 |
4 |
AS |
$0.00 |
$0 |
D/D |
(5,874) |
120,890 |
|
- |
|
540 Records found
|
|
Page 12 of 22 |
|
|